Deborah Geary, NP
Nurse Practitioner · Salem, MANPI 1881644417
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $67,980 of the $79,610 with a category attached, or 85.4%. AbbVie accounts for 95.6% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $41,817 and has fallen 87.2% since, to $5,366 in 2025. Among nurse practitioner clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 153 payments — averaging $520.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$76K
- Astrazeneca UK Limited$2K
- Novartis$357
- Jazz Pharmaceuticals Inc.$354
- E.r. Squibb & Sons, L.L.C.$264
- Gilead$208
- plus $796 from 8 others
What the payments were for
- Speaking & faculty fees$67,98085%
- Travel & lodging$7,1559%
- Food & beverage$4,4746%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 110 | $76,078 |
| Astrazeneca UK Limited | 10 | $1,552 |
| Novartis | 17 | $357 |
| Jazz Pharmaceuticals Inc. | 3 | $354 |
| E.r. Squibb & Sons, L.L.C. | 2 | $264 |
| Gilead | 2 | $208 |
| Madrigal Pharmaceuticals | 1 | $139 |
| Impulse Dynamics (USA) Inc. | 1 | $122 |
| Boehringer Ingelheim | 1 | $122 |
| Kyowa Kirin, Inc. | 1 | $119 |
| Heartflow, Inc. | 1 | $116 |
| Acadia Pharmaceuticals Inc | 2 | $87 |
| Neurocrine Biosciences, Inc. | 1 | $66 |
| Merck | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$79,610 in reported general payments places this provider in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 15 | $7,886 |
| EliquisApixaban | 13 | $4,768 |
| Metoprolol Succinate | 42 | $886 |
| Tramadol Hcl | 47 | $538 |
| Methadone Hcl | 23 | $480 |
| Ipratropium-AlbuterolIpratropium/Albuterol Sulfate | 18 | $430 |
| Warfarin Sodium | 59 | $347 |
| Quetiapine Fumarate | 14 | $244 |
| Mirtazapine | 12 | $224 |
| Lorazepam | 14 | $206 |
| Atorvastatin Calcium | 19 | $139 |
| Trazodone Hcl | 20 | $138 |
| Tamsulosin Hcl | 14 | $105 |
| Torsemide | 11 | $95 |
| Omeprazole | 11 | $81 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Salem
- Jillian OppenheimSalem$12K
- Brian FellowsSalem$10K
- Lauri WelchNorth Chelmsford$110K
- Teresa FogarenBoston$102K
- Carolyn MetivierBoston$93K
- Amberly ChaplinWorcester$56K
- Darlene MadoreBrockton$42K
- Nancy SydowN Chelmsford$35K
- Miu Lai NgBoston$33K
- Victoria Garcia AlbeaStoneham$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.